Authors: Tonin, PN Hudson, TJ Rodier, F Bossolasco, M Lee, PD Novak, J Manderson, EN Provencher, D Mes-Masson, AM

Citation: Pn. Tonin et al., Microarray analysis of gene expression mirrors the biology of an ovarian cancer model, ONCOGENE, 20(45), 2001, pp. 6617-6626

Authors: Manning, AP Abelovich, D Ghadirian, P Lambert, JA Frappier, D Provencher, D Robidoux, A Peretz, T Narod, SA Mes-Masson, AM Foulkes, WD Wang, TL Morgan, K Fujiwara, TM Tonin, PN

Citation: Ap. Manning et al., Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadianand Yemenite Jewish hereditary breast cancer families, HUMAN HERED, 52(2), 2001, pp. 116-120

Authors: Dion, F Mes-Masson, AM Seymour, RJ Provencher, D Tonin, PN

Citation: F. Dion et al., Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers, ONCOGENE, 19(11), 2000, pp. 1466-1472

Authors: Wang, JC Mes-Masson, AM Tonin, PN Provencher, D Eydoux, P

Citation: Jc. Wang et al., Trisomy of chromosome 10 in two cases of ovarian carcinoma, CANC GENET, 118(1), 2000, pp. 65-68

Authors: Manderson, EN Mes-Masson, AM Provencher, D Tonin, PN

Citation: En. Manderson et al., Mutations in a 10-bp polyadenine repeat of transforming growth factor beta-receptor type II gene is an infrequent event in human epithelial ovarian cancer, CLIN GENET, 57(2), 2000, pp. 151-153

Authors: Tonin, PN Mes-Masson, AM Narod, SA Ghadirian, P Provencher, D

Citation: Pn. Tonin et al., Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history, CLIN GENET, 55(5), 1999, pp. 318-324